
In the face of a small European outbreak of monkeypox, with the UK, Portugal, and Spain reporting confirmed cases, Bavarian Nordic has signed a contract to supply its vaccine against the infection to an undisclosed country in Europe, the company has announced in a Thursday press release.
According to Bavarian, the first recent monkeypox case was confirmed on May 7 in an individual returning from Nigeria, where the infection is endemic. Since then, more than 20 cases have been confirmed in England, Portugal, and Spain, with more suspected cases being investigated, and one case having been confirmed in the US.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app